Resilient protein co-expression network in male orbitofrontal cortex layer 2/3 during human aging.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28750307)

Published in Neurobiol Aging on July 05, 2017

Authors

Mohan Pabba1, Enzo Scifo1, Fenika Kapadia1, Yuliya S Nikolova1, Tianzhou Ma2, Naguib Mechawar3, George C Tseng4, Etienne Sibille5

Author Affiliations

1: Campbell Family Mental Health Research Institute of CAMH, Neurobiology of Depression and Aging, Toronto, Ontario, Canada.
2: Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.
3: McGill Group for Suicide Studies, Douglas Mental Health University Institute, Verdun, Quebec, Canada; Department of Psychiatry, McGill University, Montréal, Quebec, Canada.
4: Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA; Department of Human Genetics, University of Pittsburgh, Pittsburgh, PA, USA.
5: Campbell Family Mental Health Research Institute of CAMH, Neurobiology of Depression and Aging, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada. Electronic address: Etienne.sibille@camh.ca.

Articles cited by this

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol (2008) 38.00

Global quantification of mammalian gene expression control. Nature (2011) 22.36

WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics (2008) 18.58

The hallmarks of aging. Cell (2013) 14.29

Gene regulation and DNA damage in the ageing human brain. Nature (2004) 9.01

Disruption of large-scale brain systems in advanced aging. Neuron (2007) 8.12

The human orbitofrontal cortex: linking reward to hedonic experience. Nat Rev Neurosci (2005) 7.13

REST and stress resistance in ageing and Alzheimer's disease. Nature (2014) 4.38

The aging brain. Annu Rev Pathol (2008) 3.28

Depression in older adults. Annu Rev Clin Psychol (2009) 3.07

The ageing cortical synapse: hallmarks and implications for cognitive decline. Nat Rev Neurosci (2012) 2.76

The cognitive neuroscience of ageing. Nat Rev Neurosci (2012) 2.28

Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol Psychiatry (2005) 2.06

Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia. Am J Psychiatry (2010) 2.01

Changes in the structural complexity of the aged brain. Aging Cell (2007) 1.96

Sex differences in brain aging: a quantitative magnetic resonance imaging study. Arch Neurol (1998) 1.86

Detecting disease-associated genes with confounding variable adjustment and the impact on genomic meta-analysis: with application to major depressive disorder. BMC Bioinformatics (2012) 1.46

Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. J Biol Chem (2008) 1.45

Structural MRI changes detectable up to ten years before clinical Alzheimer's disease. Neurobiol Aging (2011) 1.32

Aging, the central nervous system, and mobility. J Gerontol A Biol Sci Med Sci (2013) 1.32

A Brain-Wide Study of Age-Related Changes in Functional Connectivity. Cereb Cortex (2014) 1.31

Aging and prefrontal functions: dissociating orbitofrontal and dorsolateral abilities. Neurobiol Aging (2004) 1.26

Beyond modules and hubs: the potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders. Genes Brain Behav (2013) 1.25

Epidemiology of geriatric affective disorders. Clin Geriatr Med (1992) 1.23

Anatomic evaluation of the orbitofrontal cortex in major depressive disorder. Biol Psychiatry (2004) 1.20

Glial reaction in the hippocampal formation is highly correlated with aging in human brain. Neurosci Lett (1997) 1.17

Layer-specific dendritic regression of pyramidal cells with ageing in the human prefrontal cortex. Eur J Neurosci (1998) 1.15

The challenge of the proteome dynamic range and its implications for in-depth proteomics. Proteomics (2013) 1.13

Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies. Biol Psychiatry (2009) 1.10

Molecular aspects of age-related cognitive decline: the role of GABA signaling. Trends Mol Med (2015) 1.06

Between destiny and disease: genetics and molecular pathways of human central nervous system aging. Prog Neurobiol (2010) 1.03

Proteomic sample preparation from formalin fixed and paraffin embedded tissue. J Vis Exp (2013) 1.00

Molecular aging of the brain, neuroplasticity, and vulnerability to depression and other brain-related disorders. Dialogues Clin Neurosci (2013) 0.99

Anticipated brain molecular aging in major depression. Am J Geriatr Psychiatry (2013) 0.94

Vulnerability of the orbitofrontal cortex to age-associated structural and functional brain changes. Ann N Y Acad Sci (2007) 0.94

Genic insights from integrated human proteomics in GeneCards. Database (Oxford) (2016) 0.90

Neurocognitive Aging and the Hippocampus across Species. Trends Neurosci (2015) 0.89

Proteomics identification of proteins in human cortex using multidimensional separations and MALDI tandem mass spectrometer. Mol Cell Proteomics (2007) 0.89

Brain site-specific proteome changes in aging-related dementia. Exp Mol Med (2013) 0.87

Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseases. Immun Ageing (2015) 0.86

Proteomic comparison between human young and old brains by two-dimensional gel electrophoresis and identification of proteins. Int J Dev Neurosci (2003) 0.85

Layer 2/3 pyramidal cells in the medial prefrontal cortex moderate stress induced depressive behaviors. Elife (2015) 0.85

Why are cortical GABA neurons relevant to internal focus in depression? A cross-level model linking cellular, biochemical and neural network findings. Mol Psychiatry (2014) 0.84

Immunohistochemical staining, laser capture microdissection, and filter-aided sample preparation-assisted proteomic analysis of target cell populations within tissue samples. Electrophoresis (2013) 0.84

Targeting Oxidative Stress in Central Nervous System Disorders. Trends Pharmacol Sci (2016) 0.84

Quantitative protein profiling of hippocampus during human aging. Neurobiol Aging (2015) 0.82

In vivo neuropathology of cortical changes in elderly persons with schizophrenia. Biol Psychiatry (2009) 0.82

Brain and other nervous system disorders across the lifespan - global challenges and opportunities. Nature (2015) 0.81

Proteomic analysis of the palmitoyl protein thioesterase 1 interactome in SH-SY5Y human neuroblastoma cells. J Proteomics (2015) 0.81

Decreased hippocampal expression of calbindin D28K and cognitive impairment in MELAS. J Neurol Sci (2012) 0.80

Major Shifts in Glial Regional Identity Are a Transcriptional Hallmark of Human Brain Aging. Cell Rep (2017) 0.78

Apolipoprotein D expression in human brain reactive astrocytes. J Histochem Cytochem (2003) 0.78

Altered Prefrontal Excitation/Inhibition Balance and Prefrontal Output: Markers of Aging in Human Memory Networks. Cereb Cortex (2016) 0.78

Comprehensive proteome analysis of fresh frozen and optimal cutting temperature (OCT) embedded primary non-small cell lung carcinoma by LC-MS/MS. Methods (2015) 0.77

Temporal lobe in human aging: A quantitative protein profiling study of samples from Chinese Human Brain Bank. Exp Gerontol (2015) 0.76